Latest Articles

Publication Date
Hutchmed’s Promising Phase III Study on Advanced Endometrial Cancer Treatment - MSN

Hutchmed’s Promising Phase III Study on Advanced Endometrial Cancer Treatment MSN

Published: Oct. 30, 2025, 10:54 a.m.
Iovance Biotherapeutics Advances in Endometrial Cancer Treatment with Lifileucel Study - MSN

Iovance Biotherapeutics Advances in Endometrial Cancer Treatment with Lifileucel Study MSN

Published: Oct. 30, 2025, 10:49 a.m.
Symptoms of endometrial cancer recurrence: Watch out for unusual weight loss, bleeding, pain, nausea - Moneycontrol

Symptoms of endometrial cancer recurrence: Watch out for unusual weight loss, bleeding, pain, nausea Moneycontrol

Published: Oct. 30, 2025, 8:35 a.m.
ESMO 2025: MSD and Eisai’s endometrial cancer combo shows five-year durability - MSN

ESMO 2025: MSD and Eisai’s endometrial cancer combo shows five-year durability MSN

Published: Oct. 30, 2025, 4:04 a.m.
Illustration of the positional hierarchy of endometrial epithelial stem... - researchgate.net

Illustration of the positional hierarchy of endometrial epithelial stem... researchgate.net

Published: Oct. 30, 2025, 2:21 a.m.
The Interaction of PELP1 With FHL2 Contributes to Ectopic Endometrial Stromal Cell Proliferation, Angiogenesis, and Inflammation in Endometriosis.

Endometriosis (EMS), a multifactorial and chronic benign gynecological disease characterized by ectopic endometrial growth, remains poorly understood in its pathogenesis. Proline, glutamic acid, leucine-rich protein 1 (PELP1), implicated in various …

Published: Oct. 30, 2025, midnight
SIRT7 drives energy metabolic shifts in endometriosis via interaction with TUFM and Rhoa/Rock/Akt pathway activation.

Endometriosis is characterized by the ectopic growth of endometrial-like tissue outside the uterus and altered energy metabolism, but the specific mechanisms involved remain unclear. This study aimed to investigate the …

Published: Oct. 30, 2025, midnight
Anti-Angiogenic RNAi-Based Treatment of Endometriosis in a Rat Model Using CXCR4-Targeted Peptide Nanoparticles.

Endometriosis is a common gynecological condition that affects fertility in many women of reproductive age worldwide. This multifaceted disease exhibits a pathogenesis characterized by hormonal and immune system dysregulations, alongside …

Published: Oct. 30, 2025, midnight
Defects in the DNA Damage Response of Patient-derived Endometriosis Stromal Cells.

With each menstrual cycle, endometrial cells rapidly proliferate and decidualize in preparation for pregnancy. Such rapid proliferation generates replication stress and results in DNA damage with irreparable cells undergoing senescence. …

Published: Oct. 30, 2025, midnight
Decoding uterine contractility: from physiology to pathology, through emerging technologies.

Uterine contractility has emerged as a potential key element in the orchestration of female reproductive functions, with specific motility patterns seemingly aligning with hormonal fluctuations throughout the menstrual cycle. These …

Published: Oct. 30, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!